Skip to main content

Find Clinical Trials

Home
Conditions
Gallbladder Neoplasms

Clinical trial condition

Gallbladder Neoplasms

Explore clinical trials studying Gallbladder Neoplasms. Study availability and eligibility vary by location and protocol.

214 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Gallbladder Neoplasms trial results

Completed

S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT00238212

Conditions: Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, +17 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

NCT00338988

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Cancer of the Biliary Tract, +7 more
Locations: U.T. M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen

NCT00003046

Conditions: Adenoma, Anal Cancer, Anus Diseases, +44 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

NCT00262769

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations: Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Cumberland Infirmary Carlisle, England, United Kingdom

View all 25 locations

View Trial Details

Completed

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

NCT00073905

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +21 more
Locations: Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

DX-8951f in Treating Patients With Biliary Cancer

NCT00005938

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations: University of Colorado Cancer Center Denver, Colorado, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Simmons Cancer Center - Dallas Dallas, Texas, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture

NCT01320241

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +18 more
Locations: Zhongda Hospital,Southeast University Nanjing, Jiangsu, China

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

NCT00019513

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +84 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions: AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations: National Naval Medical Center Bethesda, Maryland, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

NCT00266097

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +14 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details